Negara: Indonesia
Bahasa: Bahasa Indonesia
Sumber: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
INACTIVATED SARS-COV-2 VIRUS
BIO FARMA - Indonesia
INACTIVATED SARS-COV-2 VIRUS
3 MCG
INJEKSI
DUS, 40 VIALS @ 1 ML (2 DOSIS)
SINOVAC LIFE SCIENCES CO., LTD - China
2021-09-21
EUA-CoronaVac Health Care Provider Fact Sheet, Approved version date 05/02/2021, BPOM, ID EREG10040912100012 1 FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CORONAVAC Badan POM, the Indonesia Food and Drug Administration, has issued AN EMERGENCY USE AUTHORIZATION (EUA) to permit the emergency use of CoronaVac. CoronaVac is a vaccine which may prevent from getting COVID-19. Read this Fact Sheet for information about CoronaVac prior to provide vaccination THE EMERGENCY USE AUTHORIZATION OF the CoronaVac is to induce immunity against SARS-CoV-2 for the prevention of COVID-19. This product is suitable for people aged 18 years old and above. CoronaVac is contraindicated in person who is: 1. hypersensitive to any component of this vaccine, or 2. Primary Immunodeficiency. ADMINISTRATION: The recommended route of administration is intramuscular injection at deltoid muscle. Shake well before use. Adults, 18-59 years old _ _ • For emergency situation, the immunization schedule is 2 doses at 2-week interval (0 and 14 days), each dose is 0.5 mL. • For routine situation, the immunization schedule is 2 doses at 4-week interval (0 and 28 days), each dose is 0.5 mL. Elderly 60 years and above For immunization in elderly, schedule is 2 doses at 4-week interval (0 and 28 days, each dose is 0.5 mL. The study of CoronaVac in the elderly above 70 years old is still limited (see Clinical Studies). Booster dose has not yet been determined. CoronaVac is available as a suspension for injection packed in a 0,5 mL vial. This product contains no preservative. See the Full EUA Prescribing Information for complete dosage, administration, and preparation instructions. Health care providers must submit a report on all medication errors and ALL SERIOUS ADVERSE EVENTS related to CoronaVac. This Fact Sheet may have been updated. For more recent Fact Sheet see www.pom.go.id For information on clinical trials that are testing the use of CoronaVac in COVID-19, please see www.clinicaltrials.gov EUA-CoronaVac Health Care Baca dokumen lengkapnya